Giordano C, Picardi M, Pugliese N, Vincenzi A, Avilia S, De Fazio L, Lamagna M, Reina R, Scarpa A, Lombardi A, Vigliar E, Troncone G, Mascolo M, Mainolfi C, Fonti R, Del Vecchio S, Damiano V, Bianco R, Trastulli F, Annunziata M, Salemme A, Carchia M, Pane F. Bendamustine supercharge plus brentuximab vedotin as early salvage therapy following failure to obtain complete metabolic remission after two cycles of adriamycin-bleomycin-vinblastine-dacarbazine for classic Hodgkin lymphoma in patients aged ≤ 60 years: Long-term efficacy results of a retrospective multicentre study.
Br J Haematol 2025. [PMID:
40176291 DOI:
10.1111/bjh.20053]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/09/2025] [Accepted: 03/07/2025] [Indexed: 04/04/2025]